Want to join the conversation?
$MCHP's R&D expenses increased $6.4MM or 7.3% YoverY in 2Q16. The increase in R&D costs over the same period last year was driven by the additional costs from $MCHP's acquisition of Micrel partially offset by lower bonus costs. $MCHP expects these costs to increase over the coming quarters.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?